Ben Price

Ben Price

Director/Board Member bei PERCHERON THERAPEUTICS LIMITED

Vermögen: 54 139 $ am 31.03.2024

68 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Ben Gil Price is currently an Independent Non-Executive Director at Percheron Therapeutics Ltd., a Director at AssayQuant Technologies, Inc., and the Chief Medical Officer at KCBN Holding, Inc. He previously worked as a Clinical Development Director-Oncology at MedImmune LLC from 1997 to 2002, an Independent Director at Sarepta Therapeutics, Inc. from 2007 to 2016, a Director at Rexahn Pharmaceuticals, Inc. from 2018 to 2020, and as the Chief Executive & Medical Officer at Drug Safety Solutions LLC from 2002 to 2017.
He is also a Member of the American Medical Association, the Academy of Physicians In Clinical Research, and the American Society for Microbiology.
Dr. Price holds an undergraduate degree from the University of Rio Grande and graduate and doctorate degrees from the University of Santiago de Compostela.
He is currently serving as the President, Chief Executive & Medical Officer at NeuroBo Pharmaceuticals, Inc. until 2023.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
26.09.2023 999 805 ( 0,11% ) 54 139 $ 31.03.2024

Aktive Positionen von Ben Price

UnternehmenPositionBeginn
PERCHERON THERAPEUTICS LIMITED Director/Board Member 04.10.2021
Chief Tech/Sci/R&D Officer 01.01.2017
Assayquant Technologies, Inc. Director/Board Member -
Alle aktiven Positionen von Ben Price

Ehemalige bekannte Positionen von Ben Price

UnternehmenPositionEnde
NEUROBO PHARMACEUTICALS, INC. Chief Executive Officer 12.01.2023
REXAHN PHARMACEUTICALS, INC. Director/Board Member 01.11.2020
Drug Safety Solutions LLC Chief Executive Officer 01.07.2017
SAREPTA THERAPEUTICS, INC. Director/Board Member 01.01.2016
Corporate Officer/Principal 01.01.2002
Sehen Sie sich die Erfahrung von Ben Price im Detail an

Ausbildung von Ben Price

University of Rio Grande Undergraduate Degree
University of Santiago de Compostela Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Ben Price im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

13

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen3
SAREPTA THERAPEUTICS, INC.

Health Technology

PERCHERON THERAPEUTICS LIMITED

Health Technology

NEUROBO PHARMACEUTICALS, INC.

Health Technology

Private Unternehmen8

Health Technology

Commercial Services

Health Technology

Academy of Physicians In Clinical Research

Commercial Services

Drug Safety Solutions LLC

Miscellaneous

Assayquant Technologies, Inc.

Sehen Sie sich die Unternehmensverbindungen an